Research on opioids, addiction, and treatment. Covers traditional care practices, opioid treatment in pregnancy, illicit fentanyl, and treatment disparities.
A study published in Archives of Internal Medicine found that prescribing opioids for pain after short-stay surgery is associated with long-term analgesic use. Researchers analyzed population-based data and found that patients who received opioid prescriptions within seven days of surgery were more likely to become long-term opioid users.
A study found that Iraq and Afghanistan war veterans with mental health diagnoses, particularly post-traumatic stress disorder, are more likely to receive prescription opioid medications for pain-related conditions. This increases their risk of misuse and adverse clinical outcomes compared to those without mental health diagnoses.
A retrospective study found that methylnaltrexone (MNTX) restored bowel function and improved feeding outcomes in critically ill patients with opioid-induced constipation. MNTX was well-tolerated and showed immediate effects, improving enteral feeding and reducing gastric residual volumes.
A new study found that individuals with mood and anxiety disorders are more likely to abuse opioids. Non-medical prescription opioid use was associated with an increased risk of developing any mood disorder, major depressive disorder, bipolar disorder, and all anxiety disorders. Early identification and treatment of mood and anxiety di...
Chronic abdominal pain has seen a significant rise in opioid prescriptions, driven by factors such as campaigns to recognize pain as the "fifth vital sign". The use of opioids for non-cancer chronic pain is supported by limited evidence and can lead to gastrointestinal symptoms and worsen abdominal pain.
Chronic opioid users have longer hospital stays, more post-surgical pain and complications, and are less likely to recover fully after knee replacement surgery. Researchers recommend strategies such as weaning patients off strong opioids prior to surgery to improve patient outcomes.
A Group Health Research Institute study found that long-acting opioids and new opioid use are associated with a higher risk of pneumonia in older adults. Benzodiazepines do not seem to increase the risk, but it is crucial to look more closely at opioid prescriptions and infections.
Researchers discovered that low-dose naltrexone inhibits cell proliferation by targeting the OGF-OGFr axis, which regulates cell cycle and proliferation. This study provides new insights into the molecular pathway utilized by LDN, a clinically prescribed agent for cancer and autoimmune diseases.
Researchers at The Pennsylvania State University College of Medicine discovered that low-dose naltrexone (LDN) has a potent antitumor effect on human ovarian cancer. Combining LDN with chemotherapy resulted in an additive inhibitory action on tumorigenesis, reducing DNA synthesis and cell replication.
Despite new guidelines and educational efforts, up to 75% of surgical patients in the USA still fail to receive adequate post-op pain relief. New pain medications and techniques under development could help improve symptom relief for patients.
A review article suggests a shift towards more conservative medication-prescribing practices, considering alternative interventions and weighing risks against benefits. The authors outline seven principles for conservative prescribing, including strategic decision-making and patient-centered care.
Researchers found that naltrexone significantly reduced inflammation in Crohn's disease patients, with 88% experiencing at least a 70-point decline in symptoms after 12 weeks of treatment. The study suggests that interfering with the opioid system may lead to the reversal of inflammation.
Researchers found that 60% of substance-dependent individuals reported fair or poor oral health, with opioid users experiencing worse oral health over time. The study suggests that addressing oral health concerns may facilitate medical care discussions for addicts.
A drastic shift in prescribing patterns has led to a fivefold increase in opioid addiction admissions, with prescriptions for hydrocodone and oxycodone accounting for 84.9% of opioid scripts. Experts recommend comprehensive training and public education to protect vulnerable populations.
A study found that receiving higher prescribed doses of opioids is associated with an increased risk of opioid overdose death, but receiving both as-needed and regularly scheduled doses is not. The study included data on over 154,000 patients who received opioid therapy for pain.
Researchers at Indiana University School of Medicine have discovered an orphan drug that short-circuits the process resulting in increased sensitivity and pain from opioid use. This finding may make morphine a safer and more effective drug for chronic pain control.
A collaborative care approach with nurse care managers significantly improves treatment outcomes for patients with opioid addiction. The study found that 51% of patients achieved successful treatment at 12 months and 93% were no longer using illicit opioids after three months.
A study found that primary care physicians rarely monitor patients on prescription opioids, even those at high risk of misuse. Only a small minority of patients underwent urine drug testing, and few were seen regularly in the office.
A new study published in the journal Drug and Alcohol Dependence found that retired NFL players misuse painkillers at a higher rate than the general population, with 7% currently using opioid drugs. The study also found that players who experienced undiagnosed concussions were more likely to misused opioids.
Researchers found that opioid users experienced higher rates of serious adverse events, such as fractures and cardiac risks, compared to those taking coxibs or non-steroidal anti-inflammatory drugs. The study suggests that opioids may be associated with greater cardiovascular risk than other analgesics.
A new study published in Molecular Pain found that a single injection of morphine can strongly reduce testosterone levels in the brain and plasma of male rats. The study's findings are particularly important as testosterone is essential for various bodily functions, including cognitive functions and bone structure remodeling.
Researchers at Thomas Jefferson University have successfully tested a semi-synthetic opioid called buprenorphine to treat opioid withdrawal symptoms in infants. The treatment reduced days of hospital stay by 40% and showed promise in reducing healthcare costs, which could save up to $1 billion annually.
A $250,000 CDC grant supports a Rhode Island Hospital study exploring the effectiveness of statewide prescription monitoring programs in reducing accidental overdose deaths involving prescription opioids. The study aims to provide valuable public health data on medication access and abuse patterns.
A retrospective study of 223 patients with terminal cancer found that opioid use was both safe and effective in the home setting. Patients who received higher doses had a longer median survival time compared to those who received lower doses.
Researchers discovered that the OGF-OGFr axis controls entry from cytoplasm to nucleus, critical for cell proliferation. Nucleocytoplasmic transport involves karyopherin β and Ran, and is dependent on nuclear localization signals.
Researchers have discovered a novel approach to ease chronic and acute pain caused by sickle cell disease, using cannibinoids that equally lessen pain in animals as opioids, but with much smaller doses. The treatment has great promise for patients with this genetic blood disorder.
A pre-emptive multimodal pain regimen reduced opioid analgesic use in robotic prostatectomy patients. The study found a mean opioid dose of 49.1 mg for those receiving the regimen, compared to 75.3 mg for standard care.
Research reveals that group visits can significantly improve blood pressure in diabetics with hypertension but not blood sugar levels. Colorectal cancer risk increases with age and birth cohort, suggesting a potential burden to society. Opioid treatment agreements may not reduce misuse, and a new complication from contaminated cocaine ...
A genetic variant of a brain receptor influences dopamine release in response to alcohol, which may contribute to individual differences in alcohol use disorders. This finding aids the development of personalized medications for alcohol problems and explains why some individuals experience enhanced pleasurable effects from alcohol.
The new Canadian practice guideline addresses improper use of opioids in chronic non-cancer pain management. The guideline provides recommendations for safe and effective opioid therapy, with a focus on risk stratification, patient selection, and monitoring.
A European study finds inadequate access to opioid-based pain relief for cancer patients, with some countries restricting essential medicines. The authors conclude that restrictive regulations hinder medical care and recommend revising laws to improve accessibility.
A study of nearly 10,000 patients found that those receiving higher opioid doses were 9 times more likely to overdose compared to those on lower doses. The researchers strongly associate the risk with prescribed dose, highlighting the need for cautious prescribing practices.
Researchers found prescribed opioids associated with significant overdose risk. Leptin therapy holds promise for long-term weight loss. Atrial fibrillation risk is lower with certain antihypertensives, while higher statin doses may not always prevent coronary artery disease.
Researchers at Georgia State University discovered that infant pain can lead to altered brain processing of pain in adulthood. Infants who spent time in the NICU show increased opioid levels and decreased mu and delta opioid receptors, affecting pain medication efficacy.
Alcohol consumption during pregnancy can lead to a range of adverse outcomes, including learning disabilities and increased susceptibility to diseases. The destruction of beta-endorphin neurons in the hypothalamus region can result in permanent impairment of stress and immune system functions throughout life.
A study of high school seniors found that most who took opioid medications without a prescription did so for reasons other than pain relief, including relaxation and getting high. Students who used the drugs only for pain relief were less likely to engage in heavy drinking or other substance use.
The review examines the prevalence of prescription opioid addiction among patients and healthcare providers, citing risks and consequences. New approaches to minimize abuse and promote recovery are discussed, emphasizing the importance of awareness and treatment.
The Opioid Growth Factor (OGF) and its receptor (OGFr) play a crucial role in regulating cell proliferation by modulating cyclin-dependent kinase inhibitors. The study found that transport of OGFr into the nucleus required two out of three nuclear localization signals, highlighting the importance of this pathway in cancer treatment.
A new study found that naltrexone significantly decreases heavy drinking rates in smokers enrolled in smoking cessation, with the heaviest drinkers benefiting the most. The medication's potential benefits for co-use of nicotine and alcohol may provide a helpful addition to standard quitting programs.
A rodent study confirms that low to moderate levels of alcohol increase beta-endorphin release in the midbrain/Ventral Tegmental Area (VTA) region, producing a general feeling of well-being. This supports a role of beta-endorphin in mediating some of the rewarding effects of alcohol.
Research reveals that chronic alcohol consumption alters neural systems in the brain, leading to cognitive deficits and disorders of memory and learning. Dynorphins, a key player in this process, are found to be upregulated in the prefrontal cortex and hippocampus, impairing learning and memory.
A recent study found that over 10 million Americans use opioids, with 4 million using them regularly, reflecting a need to strike a balance between opioid misuse and chronic pain control. Opioid regular use increased with age, decreased with education level, and was more common in females and non-Hispanic whites.
Researchers discovered that imiquimod, an immune response modifier, relies on the Opioid Growth Factor (OGF)-OGF receptor axis for its action. This finding provides new insights into the mechanism of imiquimod's antiviral and antitumor activity.
Research presented at the American Pain Society annual meeting found that less than 3% of patients with no history of drug abuse who are prescribed opioids for chronic pain will show signs of possible drug abuse or dependence. Most chronic pain patients do not rely on drugs as a sole solution, and multi-faceted treatment involving phys...
A new policy implemented in a Michigan clinic helped identify 35% of patients misusing opioid medications, while steering dependent patients to treatment. The approach logged and screened all patients receiving opioids for non-cancer pain, with the goal of protecting doctors' ability to prescribe these drugs.
A new study found that black and Hispanic patients are less likely to receive strong pain drugs in emergency rooms, despite increased opioid use. Non-opioid pain relievers were prescribed more often to non-whites than whites.
A study found that many cancer patients with metastatic disease incorrectly believe opioids are only for dying patients. Morphine can improve pain management and quality of life for living patients. Experts stress the importance of professional confidence in opioid use to change these beliefs.
A Phase 2 study showed ALO-01, an extended-release morphine sulfate plus sequestered naltrexone, provided similar effectiveness and tolerability to KADIAN Capsules for moderate-to-severe chronic osteoarthritis pain. The majority of patients rated both medications as good or excellent.
The study demonstrated similar release characteristics of the product to those found in previous studies of Alpharma's currently marketed KADIAN Capsules. The company is targeting an NDA filing for its abuse-deterrent product in the first half of 2008.
A recent study found that morphine's effectiveness in pain relief does not correlate with patient survival time. In fact, patients with no opioid experience are at risk of respiratory depression, while those with moderate-to-severe chronic pain are not. This challenges the common misconception that morphine is deadly.
New research published in Palliative Medicine challenges the misconception that morphine is a lethal drug. The study found no significant changes in vital statistics when patients with severe cancer pain were treated with morphine. Morphine's wide safety margin and effectiveness in managing pain have been confirmed.
A Phase IV study found that Kadian's extended-release mechanism is maintained even in the presence of significant amounts of alcohol. The concomitant use of tested levels of alcohol with Kadian has no significant impact on morphine blood levels or release timing.
A systematic literature review found that opioids are effective only in the short-term (less than four months) treatment of chronic low back pain. Long-term effectiveness is not conclusive, and behaviors consistent with opioid abuse were reported in 24 percent of cases.
A study analyzed 227 adult patients with neck pain who participated in a larger prospective, randomized, open-label study. After four weeks, patients reported a 30.7% reduction in pain intensity, suggesting that Kadian offers broad utility for even the most disabling types of chronic pain.
Researchers at Mayo Clinic have identified two cases of 'broken heart syndrome,' a rare condition that mimics a heart attack, resulting from opioid withdrawal and cocaine use. The findings highlight the importance of cautious medication management and patient education to prevent serious complications.
A study found that new mothers experience six common postpartum symptoms, including fatigue, breast discomfort, and decreased desire for sex. Women who had cesarean sections reported significantly worse physical health than those who gave birth vaginally. Breastfeeding was also linked to more symptoms.
Researchers explore rheumatic pain mechanisms, debunking common misconceptions. Comprehensive treatment approaches are discussed, including exercise, dietary supplements, and opioid analgesics.
A study of 173 children aged 2-16 years found that fentanyl patches improved subjective pain and quality of life. The patches were well-tolerated with no significant adverse effects compared to adults, making them a suitable option for managing chronic severe pain in pediatric patients.
A study of 292 health care professionals found that a family history of substance use disorder, major opioid use, and coexisting psychiatric disorders significantly increased the risk of relapse. The study suggests that intensive monitoring and tailored treatment plans can help prevent relapse among high-risk healthcare professionals.
A study of 750 women in spontaneous labor found no significant difference in C-section rates between those receiving spinal and systemic opioids. Early epidural analgesia was also associated with shorter labors and lower pain scores.